WWW.JNEUROSCI.ORG
-
The Journal of Neuroscience
 QUICK SEARCH:   [advanced]


     
-


HOME
  |  
SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (24)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vazquez, J.
Right arrow Articles by Baghdoyan, H. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vazquez, J.
Right arrow Articles by Baghdoyan, H. A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

 Previous Article  |  Next Article 

The Journal of Neuroscience, July 1, 2002, 22(13):5597-5605

The Nitric Oxide Synthase Inhibitor NG-Nitro-L-Arginine Increases Basal Forebrain Acetylcholine Release during Sleep and Wakefulness

Jacqueline Vazquez1, 2, Ralph Lydic1, and Helen A. Baghdoyan1

1 Department of Anesthesiology, University of Michigan, Ann Arbor, Michigan 48109, and 2 Department of Neuroscience and Anatomy, The Pennsylvania State University, Hershey, Pennsylvania 17033

Cholinergic neurotransmission in the basal forebrain changes across the sleep/wake cycle, and considerable data show cortical activation by ACh originating from basal forebrain neurons. These findings have stimulated efforts to elucidate molecular modulators of ACh release within the basal forebrain. Basal forebrain cholinergic neurons contain nitric oxide synthase (NOS), the enzyme that produces the gaseous neuromodulator nitric oxide. This study tested the hypothesis that administration of an NOS inhibitor to the basal forebrain would alter basal forebrain ACh release, sleep, and respiratory rate. Seven cats were instrumented for recording sleep and wakefulness and for in vivo microdialysis and microinjection. Compared with Ringer's solution (control), microdialysis delivery of the NOS inhibitor NG-nitro-L-arginine (NLA; 10 mM) increased ACh release during wakefulness (33%), non-rapid eye movement (NREM) sleep (70%), and rapid eye movement (REM) sleep (16%). Mean ± SEM ACh levels (pmol/10 min) during control and NLA dialysis, respectively, were 0.58 ± 0.03 and 0.77 ± 0.06 in wakefulness, 0.36 ± 0.01 and 0.61 ± 0.06 in NREM sleep, and 0.68 ± 0.06 and 0.79 ± 0.09 in REM sleep. Increases in ACh release were not evoked by dialysis delivery of the less active enantiomer NG-nitro-D-arginine. Dialysis administration of NLA did not alter respiratory rate. Sleep-dependent changes in basal forebrain ACh release were localized specifically to lateral basal forebrain regions and did not occur in medial basal forebrain sites. Microinjection of NLA into the lateral basal forebrain did not significantly alter the sleep/wake cycle. In contrast to NLA-induced depression of REM sleep and ACh release in the cat pons, the present results demonstrate that NLA increased ACh release in the cat basal forebrain and had no effect on sleep. The different effects of NLA on ACh release in the cat pons and cat basal forebrain may prove relevant for developing compounds that differentially alter cholinergic neurotransmission in specific brain regions.

Key words: basal forebrain; in vivo microdialysis; nitric oxide; NG-nitro-L-arginine; sleep; substantia innominata


Copyright © 2002 Society for Neuroscience  0270-6474/02/22135597-09$05.00/0


This article has been cited by other articles:


Home page
J. Appl. Physiol.Home page
R. Lydic, R. Garza-Grande, R. Struthers, and H. A. Baghdoyan
Nitric oxide in B6 mouse and nitric oxide-sensitive soluble guanylate cyclase in cat modulate acetylcholine release in pontine reticular formation
J Appl Physiol, May 1, 2006; 100(5): 1666 - 1673.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
J. Vazquez and H. A. Baghdoyan
GABAA Receptors Inhibit Acetylcholine Release in Cat Pontine Reticular Formation: Implications for REM Sleep Regulation
J Neurophysiol, October 1, 2004; 92(4): 2198 - 2206.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Marino and J. Cudeiro
Nitric Oxide-Mediated Cortical Activation: A Diffuse Wake-Up System
J. Neurosci., May 15, 2003; 23(10): 4299 - 4307.
[Abstract] [Full Text] [PDF]



-
-

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help

-
Copyright 2009 by Society for Neuroscience ONLINE ISSN: 1529-2401
-